Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sam P Ingram"'
Autor:
Greg J. Duncan, Sam D. Ingram, Katie Emberley, Jo Hill, Christian Cordano, Ahmed Abdelhak, Michael McCane, Jennifer E. Jenks, Nora Jabassini, Kirtana Ananth, Skylar J. Ferrara, Brittany Stedelin, Benjamin Sivyer, Sue A. Aicher, Thomas S. Scanlan, Trent A. Watkins, Anusha Mishra, Jonathan W. Nelson, Ari J. Green, Ben Emery
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Chronic demyelination and oligodendrocyte loss deprive neurons of crucial support. It is the degeneration of neurons and their connections that drives progressive disability in demyelinating disease. However, whether chronic demyelination tr
Externí odkaz:
https://doaj.org/article/157dbf6e704c453ab56f2275e3086749
Autor:
Sam S. Ingram, Tyler M. Wilson, Joseph S. Wilson, Emma A. Ziebarth, MaKenna C. Johnson, Jacob G. Young, Richard E. Carlson
Publikováno v:
Seeds, Vol 3, Iss 2, Pp 276-285 (2024)
Lavandula angustifolia Mill., lavender, is an aromatic plant in the Lamiaceae family. Lavender is an important economic plant that is cultivated throughout the world. Previous studies have shown that the primary pollinators of lavender in Europe and
Externí odkaz:
https://doaj.org/article/c62651843dd4489aa6c42ee100129447
Autor:
Neil G Burnet, Thomas Mee, Simona Gaito, Norman F Kirkby, Adam H Aitkenhead, Carmel N Anandadas, Marianne C Aznar, Lisa H Barraclough, Gerben Borst, Frances C Charlwood, Matthew Clarke, Rovel J Colaco, Adrian M Crellin, Noemie N Defourney, Christina J Hague, Margaret Harris, Nicholas T Henthorn, Kirsten I Hopkins, E Hwang, Sam P Ingram, Karen J Kirkby, Lip W Lee, David Lines, Zoe Lingard, Matthew Lowe, Ranald I Mackay, Catherine A McBain, Michael J Merchant, David J Noble, Shermaine Pan, James M Price, Ganesh Radhakrishna, David Reboredo-Gil, Ahmed Salem, Srijith Sashidharan, Peter Sitch, Ed Smith, Edward AK Smith, Michael J Taylor, David J Thomson, Nicola J Thorp, Tracy SA Underwood, John W Warmenhoven, James P Wylie, Gillian Whitfield
Publikováno v:
Burnet, N G, Mee, T, Gaito, S, Kirkby, N F, Aitkenhead, A H, Anandadas, C N, Aznar, M C, Barraclough, L H, Borst, G, Charlwood, F C, Clarke, M, Colaco, R J, Crellin, A M, Defourney, N N, Hague, C J, Harris, M, Henthorn, N T, Hopkins, K I, Hwang, E, Ingram, S P, Kirkby, K J, Lee, L W, Lines, D, Lingard, Z, Lowe, M, Mackay, R I, McBain, C A, Merchant, M J, Noble, D J, Pan, S, Price, J M, Radhakrishna, G, Reboredo-Gil, D, Salem, A, Sashidharan, S, Sitch, P, Smith, E, Smith, E A, Taylor, M J, Thomson, D J, Thorp, N J, Underwood, T S, Warmenhoven, J W, Wylie, J P & Whitfield, G 2022, ' Estimating the percentage of patients who might benefit from proton beam therapy instead of X-ray radiotherapy ', The British journal of radiology, vol. 95, no. 1133, A5, pp. 20211175 . https://doi.org/10.1259/bjr.20211175
Objectives: High-energy Proton Beam Therapy (PBT) commenced in England in 2018 and NHS England commissions PBT for 1.5% of patients receiving radical radiotherapy. We sought expert opinion on the level of provision. Methods: Invitations were sent to